Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Loh

Showing results (281-290 of 479) with videos related to

Pageof 48
Sort By:
Clinical Nephrology|September 20, 2016
30-year follow-up study of IgA nephritis in a Southeast Asian population: an evaluation of the Oxford histological classification
Keng Thye Woo, Cynthia C Lim, Marjorie W Y Foo, et al.
Pediatric Blood & Cancer|February 24, 2015
Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology GroupElliot Stieglitz, Ashley F Ward, Robert B Gerbing, et al.
Pediatric Blood & Cancer|January 5, 2026
Diminished Quality of Life Despite Reduced Treatment in Children With B-Lymphoblastic Leukemia: Children's Oncology Group AALL0932Lyn M Balsamo, John A Kairalla, Emily Hibbitts, et al.
Blood|October 27, 2020
Genetics of osteonecrosis in pediatric acute lymphoblastic leukemia and general populationsWenjian Yang, Meenakshi Devidas, Yiwei Liu, et al.
Journal of the National Cancer Institute|May 13, 2022
Persistence of Chemotherapy-Induced Peripheral Neuropathy Despite Vincristine Reduction in Childhood B-Acute Lymphoblastic LeukemiaRozalyn L Rodwin, John A Kairalla, Emily Hibbitts, et al.
Cancer|December 22, 2017
Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131Wanda L Salzer, Michael J Burke, Meenakshi Devidas, et al.
Blood|December 3, 2003
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesisMignon L Loh, Shashaank Vattikuti, Suzanne Schubbert, et al.
Blood Advances|April 15, 2026
Adding Induction Intrathecal Cytarabine in Newly Diagnosed CNS2 B-Acute Lymphoblastic Leukemia Does Not Improve OutcomesCathy A Lee-Miller, John A Kairalla, Emily Hibbitts, et al.
Blood Advances|September 28, 2021
Simple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemiaHironobu Kitazawa, Yusuke Okuno, Hideki Muramatsu, et al.
Haematologica|January 26, 2023
Venetoclax and dinaciclib elicit synergistic preclinical efficacy against hypodiploid acute lymphoblastic leukemiaHolly Pariury, Joshua Fandel, Stefanie Bachl, et al.
Pageof 48

Showing results (281-290 of 479) with videos related to

Sort By:
Pageof 48
Clinical Nephrology|September 20, 2016
30-year follow-up study of IgA nephritis in a Southeast Asian population: an evaluation of the Oxford histological classification
Keng Thye Woo, Cynthia C Lim, Marjorie W Y Foo, et al.
Pediatric Blood & Cancer|February 24, 2015
Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology GroupElliot Stieglitz, Ashley F Ward, Robert B Gerbing, et al.
Pediatric Blood & Cancer|January 5, 2026
Diminished Quality of Life Despite Reduced Treatment in Children With B-Lymphoblastic Leukemia: Children's Oncology Group AALL0932Lyn M Balsamo, John A Kairalla, Emily Hibbitts, et al.
Blood|October 27, 2020
Genetics of osteonecrosis in pediatric acute lymphoblastic leukemia and general populationsWenjian Yang, Meenakshi Devidas, Yiwei Liu, et al.
Journal of the National Cancer Institute|May 13, 2022
Persistence of Chemotherapy-Induced Peripheral Neuropathy Despite Vincristine Reduction in Childhood B-Acute Lymphoblastic LeukemiaRozalyn L Rodwin, John A Kairalla, Emily Hibbitts, et al.
Cancer|December 22, 2017
Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131Wanda L Salzer, Michael J Burke, Meenakshi Devidas, et al.
Blood|December 3, 2003
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesisMignon L Loh, Shashaank Vattikuti, Suzanne Schubbert, et al.
Blood Advances|April 15, 2026
Adding Induction Intrathecal Cytarabine in Newly Diagnosed CNS2 B-Acute Lymphoblastic Leukemia Does Not Improve OutcomesCathy A Lee-Miller, John A Kairalla, Emily Hibbitts, et al.
Blood Advances|September 28, 2021
Simple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemiaHironobu Kitazawa, Yusuke Okuno, Hideki Muramatsu, et al.
Haematologica|January 26, 2023
Venetoclax and dinaciclib elicit synergistic preclinical efficacy against hypodiploid acute lymphoblastic leukemiaHolly Pariury, Joshua Fandel, Stefanie Bachl, et al.
Pageof 48